Aesthetic Medicine Market Likely To Reach $11.9 Billion By 2022: Grand View Research, Inc.

San Francisco, United States, 2018-Sep-14 — /EPR Network/ —The global aesthetic medicine market is expected to reach USD 11.9 billion by 2022, according to a new report by Grand View Research, Inc. Some key drivers of the market include growth in aging population, increasing disposable income, and increasing awareness about the efficacy of aesthetic treatments.

People aged between 25 to 65 years have prominent aging signs such as wrinkles, fine lines, and dark spots. For instance, according to the CIA World Fact Book, approximately 47.2% of the total population of China was aged between 25 to 54 years in 2014. Growth in geriatric population is likely to boost demand via widening the consumer base.

Moreover, the need for improved aesthetics in the growing working class population is likely to boost usage rates over the forecast period. For instance, according to sources, the U.S. alone had a working population of 139.206 million in 2011. With improving employment rates especially in the emerging markets, the demand for aesthetic medicine is going to advance over the forecast period.

However, the presence of stringent regulatory framework to ensure product safety and efficacy is one of the prime factors limiting the growth of the global aesthetic medicine market. Moreover, surgical and minimally invasive procedures require skilled professionals. This coupled with the growing overall treatment cost, is expected to restraint market growth.

To request a sample copy or view summary of this report:

Further key findings from the study suggest:

  • Anti-wrinkle products accounted for the largest market share of 50.2% in 2014 owing to high consumer awareness levels regarding product availability, affordable cost, and high efficacy rates
  • The segment is expected to maintain its dominance throughout the forecast period. Minimally invasive technique, lesser side effects, and better results are some factors that are expected to drive the anti-wrinkle market towards expedited growth
  • Botulinum toxin is one of the oldest anti-wrinkle products available in the market. Therefore, awareness about the effectiveness of this product is high as compared to other products, resulting in the segment dominating in terms of revenue share.
  • Hyaluronic acid owing to, low side effects and high efficacy rates also accounted for a large market share in 2014
  • Clinics and beauty centers, was the largest end-use segment in 2014 as majority of the techniques demand skilled professionals to perform the procedure. Moreover, stringent regulatory guidelines limit the use of high-risk devices and treatments to professionals. As a result, the clinics and beauty center segment is expected to maintain its market position throughout the forecast period.
  • Asia pacific accounted for the largest market share of around 32.5% in 2014. Growing penetration of the technologically advanced products, cheaper treatment cost, and presence of skilled professionals are some factors driving regional growth. Moreover, growing popularity of the emerging Asia Pacific countries as medical tourism hubs will boost demand over the forecast period.
  • The presence of a large target population pool in China and India between 25 to 65 years coupled with rapidly increasing disposable income and improving standards of living is spurring the demand for aesthetic medicine in this region.
  • Some key players operating in the global market include Allergan, Inc., Alma Laser, Cynosure, Galderma S.A., Lumenis, Johnson and Johnson, Solta Medical, Inc. and Syneron Medical Ltd.

Related Report of Medical Devices:

Grand View Research has segmented the aesthetic medicine market on the basis of product type, end-use, and region:

Global Aesthetic Medicine Product Outlook, 2012 – 2022 (USD Million)

  • Energy Based Devices
    • Aesthetic Laser Devices
    • Body Contouring Devices
    • Microdermabrasion
    • Ultrasound
  • Implants
  • Anti-wrinkle products
    • Botulinum toxin
    • Dermal Fillers
    • Chemical Peel

Global Aesthetic Medicine End-use Outlook, 2012 – 2022 (USD Million)

  • Clinics and Beauty Centers
  • Home Use

Aesthetic Medicine Regional Outlook, 2012 – 2022 (USD Million)

  • North America
    • U.S. Aesthetic Medicine Marketby Product Type
    • Canada Aesthetic Medicine Marketby Product Type
    • U.S. Aesthetic Medicine Marketby End-use
    • Canada Aesthetic Medicine Marketby End-use
  • Europe
    • Germany Aesthetic Medicine Marketby Product Type
    • France Aesthetic Medicine Marketby Product Type
    • Germany Aesthetic Medicine Marketby End-use
    • France Aesthetic Medicine Marketby End-use
  • Asia Pacific
    • South Korea Aesthetic Medicine Marketby Product Type
    • Japan Aesthetic Medicine Marketby Product Type
    • South Korea Aesthetic Medicine Marketby End-use
    • Japan Aesthetic Medicine Marketby End-use
  • Latin America
    • Brazil Aesthetic Medicine Marketby Product Type
    • Mexico Aesthetic Medicine Marketby Product Type
    • Brazil Aesthetic Medicine Marketby End-use
    • Mexico Aesthetic Medicine Marketby End-use
  • MEA
    • South Africa Aesthetic Medicine Marketby Product Type
    • South Africa Aesthetic Medicine Marketby End-use

Access Press Release Of This Research Report by Grand View Research:

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.


Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519


For More Info:

Matched content

Editor’s pick